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The Maturing of Hormesis as a Credible 
Dose-Response Model 
Edward J. Calabrese 
Environmental Health Sciences, School of Public Health, University of Massachusetts, 
Amherst, MA 
ABSTRACT 
Hormesis is a dose-response phenomenon that has received little recognition, 
credibility and acceptance as evidenced by its absence from major toxicological/risk 
assessment texts, governmental regulatory dose-response modeling for risk assess- 
ment, and non-visibility in major professional toxicological society national meet- 
ings. This paper traces the historical evolution of the hormetic dose-response hy- 
pothesis, why this model is not only credible but also more common than the widely 
accepted threshold model in direct comparative evaluation, and how the toxicologi- 
cal community made a critical error in rejecting hormesis, a rejection sustained over 
70 years. 
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INTRODUCTION 
The central pillar of toxicology is that of the dose-response relationship. The na- 
ture of the dose response has long been assumed to follow a threshold model (Bliss, 
1935a, 1935b, 1935c; Clarke, 1937; Finney, 1952; Gaddum, 1953). This has been 
especially the situation for non-carcinogens. In the case of carcinogens, regulatory 
agencies such as the EPA and FDA have assumed that the shape of the dose response 
* Effort sponsored by the Air Force Office of Scientific Research, Air Force Material Com- 
mand, USAF, under grant number F49620-9%1-0091. The U.S. Government is authorized 
to reproduce and distribute for governmental purposes notwithstanding any copyright 
notation thereon. The views and conclusions contained herein are those of the authors 
and should not be interpreted as necessarily representing the official policies or endorse- 
ment, either expressed or implied, of the Air Force Office of Scientific Research or the 
U.S. Government. 
Address correspondence to Edward J. Calabrese, Environmental Health Sciences, School 
of Public Health, University of Massachusetts, Amherst, MA 01003, USA. Tel: 413-545- 
3164. Fax: 4134454692. E-mail: edwardc@schoolph.umass.edu 
1
Calabrese: The Maturing of Hormesis as a Credible Dose-Response Model
Published by ScholarWorks@UMass Amherst, 2007
E.J. Calabrese 
is linear at low doses based principally on a conservative precautionary-type philos- 
ophy. Advocates for either a threshold or linear model perspective have engaged in 
a long-term debate over the biological plausibility of their respective models, espe- 
cially in the contentious area of carcinogen risk assessment/regulation. While the 
threshold vs linearity at low-dose debate has cast a dominant shadow over the field 
of risk assessment for nearly three decades, in this paper we propose that the most 
fundamental shape of the dose-response relationship is neither threshold nor linear 
but U-shaped. This challenge for the primacy of dose-response model dominance 
in toxicology and, in fact, the vast array of biological disciplines by the U-shaped 
perspective cuts to the core beliefs of the field wit11 extremely significant evolution- 
ary, ecological, biomedical, clinical, economic and social implications (Calabrese 
and Baldwin, 2001a). The present paper will establish that the hormetic dose re- 
sponse is the most dominant dose-response model in toxicology based on objective, 
head-to-head comparison with the threshold model; it will demonstrate how the 
toxicological community missed this basic feature of the dose response, a mistake 
of historical proportions and implications; it will also provide a mechanistic frame- 
work that can account for quantitative features of the hormetic dose response. This 
evaluation will be placed within an historical context to enhance a balanced under- 
standing of the unfolding of toxicological thought concerning the dose-response 
throughout the past century. The paper argues that the hormetic dose response is 
the central dose-response model in toxicology and needs to be included in all lead- 
ing texts and taught as a routine feature of toxicological instruction dealing with the 
dose response and principles of risk assessment. 
DEFINITION 
The U-shaped dose response model is commonly referred to as hormesis, a dose 
response phenomenon characterized by a low-dose stimulation and a high dose 
inhibition. This dose response may take the shape of either the inverted U or a 
J-shaped dose response depending on the endpoint that is measured (Figure 1). 
In the case of the inverted U-shaped dose response, this may be observed when 
endpoints such as growth, fecundity and longevity are measured. In the case of 
J-shaped dose response relationships, this may be observed when endpoints such as 
disease incidence are measured. 
While the hormetic dose response is often described as either an inverted U- or 
J-shaped dose response, it is best described as a dose-time-response, in which there 
is an initial disruption of homeostasis (i.e., toxicity) followed by a modest overcom- 
pensation response which eventually leads to a re-establishment of homeostasis. It 
is this modest overcompensation response which is seen as the hormetic low-dose 
stimulation (Figure 2) (Calabrese and Baldwin, 2001c, 2002a). 
HISTORICAL PERSPECTIVES 
The phenomenon of hormesis has had a long, but spotty history. For the most 
part it has been a marginalized dose-response theory with occasional vocal advocates 
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Figwe 1. (A) The most common form of the hormetic dose-response curve depicting low- 
dose stimulatory and high-dose inhibitory responses, the B- or inverted U-shaped 
curve. Endpoints displaying this curve include growth, fecundity and longevity. 
(B) The hormetic dose-response curve depicting low-dose reduction and high- 
dose enhancement of adverse effects. Endpoints displaying this curve include 
carcinogenesis, mutagenesis and disease incidence. 
over the past century. Once toxicology became a reasonably well organized and 
professional discipline this dose-response theory found itself excluded from the 
principal textbooks, developments of professional societies and the activities of an 
ever dominant governmental toxicological/risk assessment influence. Despite this 
shunned perspective by the dominant influences in the field of toxicology over the 
past '70 to 80 years, there has been a continuous flow of articles published that 
provides support to this hypothesis across the broad spectrum of biological sub- 
disciplines. 
The term hormesis entered the scientific literature in 1943 when Southam and 
Ehrlich reported that extracts from the red cedar tree enhanced the metabolism of 
fungi at low concentrations but inhibited it at higher concentrations. These inves- 
tigators were apparently unaware of a substantial body of literature that described 
similar dose responses in plants, microorganisms, insects, and mammalian models 
from a variety of chemical agents, including most of the well-studied inorganic con- 
taminants as well as various forms of radioactivity (Calabrese and Baldwin, 2000a-e). 
The primacy of the concept of hormesis is generally credited to Hugo Scl~ulz, a 
pharmacologist at the University of Greifswald in northern Germany who based ex- 
periments dealing with the effects of disinfectants on the metabolism of yeasts in 
the mid 1880s (Schulz, 188'7). The terminology that grew up around the concept of 
hormesis reflected the culture of the time, which had a tendency to name phenom- 
ena after their discoverers and to quickly conclude that they reflected some type of 
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Figure 2. (A) The general form of hormetic dose-response relationships; (B) the temporal 
sequence of hormetic dose-response relationships. 
biological "Law." Thus, the initial observations of Schulz along with his attempts to 
generalize the concept resulted in this phenomenon being called the Amdt-Schulz 
Law or Hueppe's Rule, after the bacteriologist who extended the findings to bac- 
teria (Hueppe, 1896). However, these terms are rarely used today, giving way to 
hormesis or other terms such as U- orJ-shaped, biphasic dose response, dual effects, 
bidirectional responses and several others. 
The early history of what are now called hormetic effects was surprisingly im- 
pressive. This phenomenon attracted a number of well-known researchers who pub- 
lished their findings in the leading journals of the day. A detailed assessment of 
the historical foundations of chemical and radiation hormesis has been published 
by Calabrese and Baldwin (2000a-e). Even more impressive was the fact that sev- 
eral of the early leading hormetic researchers were direct descendants from Nobel 
Prize winners' laboratories such as Ferdinand Hueppe (see Hueppe, 1896) from 
Robert Koch's lab, Louis Kahlenberg (University of Wisconsin) (see Kahlenberg and 
The,  1896a,b) from Willhem Ostwald's lab, and Charles Richet (1905,1906-190'7), a 
Nobel Prize winner for the discovery of anaphylaxsis. Other early leaders in hormetic 
research with outstanding scientific reputations were Charles Edward Winslow (see 
Winslow and Dolloff, 1928; Winslow and Haywood, 1931; Falk, 1923) atYale Univer- 
sity, Benjamin Duggar (1 901, 1936) of Cornell University/University of Wisconsin, 
and Jensen (190'7) at Stanford University. Due to the fact that X-rays and radionu- 
clides were discovered about a decade after the initial research of Schulz, the 
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association of radioactivity and hormesis was delayed relative to chemical findings. 
Nonetheless, substantial evidence emerged by the early 1920s that radiation-induced 
biphasic dose-response relationships were considered common, reproducible and 
independent of biological model (Calabrese and Baldwin, 2000c-d). In fact, the 
hormetic dose response was commonly reported and diagrammed in leading texts on 
botany and microbiology into the middle decades of the twentieth century (Marshall 
and Hrenoff, 1937). 
Despite the initial decades of successf~~l hometic research it became the object 
of opponents who successfully linked it with the medical practice of homeopathy 
(Clark, 1937). This was an easy thing to do since the creator of the concept of 
hormesis, Hugo Schulz, was a very strong proponent of homeopathy and in fact 
interpreted his findings as providing the scientific foundations of the medical prac- 
tice of homeopathy. In fact, the Arndt-Schulz Law was named, in part, after R~ldolph 
Arndt, a homeopathic physician. As a result of the very close association between the 
Arndt-Schulz Law and homeopathy it became targeted by enemies of homeopathy in 
the long-running confrontation with what is today called traditional medicine. Even 
today, the proponents of homeopathy still point to the work of Schulz as providing 
important historical foundations of the biological basis of homeopathy (Bellevite 
et al., 1997). However, in the early decades of the twentieth century the homeopa- 
thy movement had major setbacks with numerous homeopathic medical schools in 
the U.S. being forced to close due to poor academic standards. How these actions 
affected the Arndt-Schulz Law has never been studied but it is likely that it negatively 
impacted its general recognition and acceptance. In fact, as early as 1896 Hueppe 
argued that the findings of Schulz were reproducible and needed to be judged on 
their own merits, not coupled wit11 homeopathy, even though this was how Schulz 
himself framed the question. 
The downfall of the Arndt-Schulz Law, however, cannot be solely laid at the feet of 
its close association with homeopathy. It had a number of other limitations of notable 
importance that combined to make this theory play scientific catch-up throughout 
the remainder of the century. For example, the proponents of the Arndt-Schultz 
Law attempted to transform this dose-response theory into a range of profitable 
businesses, claiming, for example, that low doses of radium could be used not only 
as a human elixir but also as a fertilizer for plants at low doses. In both cases it 
had major public relations failures. In the case of the elixir, its greatest proponent, 
Eben Evers, died a very public and painful death from radium-induced bone cancer. 
In the case of radium as a fertilizer, the findings were consistently equivocal; most 
notably was the 1948 13site USDA study although it had important study design 
weaknesses (Alexander, 1950). In addition, the emphasis on the nature of the dose 
response during the 1920s and 1930s was not on low-dose effects; in fact, just the 
opposite. Issues that received greatest attention were the effects of disinfectants on 
microbes, the effects of pesticides on awide range of organisms, as well as protection 
of workers from toxic substances. These cases involved instances of high-dose effects. 
Furthermore, it was evident that the investigations of that era did not address the 
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quantitative features of the hormetic dose response, which in fact are rather modest, 
at least as far as the low-dose stimulation is concerned. 
By the 1930s, the collective criticisms of the Arndt-Schulz Law had significantly 
eroded many of the earlier gains it had made in both the chemical and radiation do- 
mains. Despite the legitimacy of many of these criticisms, this was unfortunate since 
the clata underlying the hormetic hypothesis were generally sound and substantial. 
However, as is common in such debates, commercial claims were often proven wrong 
while scientific limitations were often exaggerated. This fall from centrality within 
the scientific community during the early 1930s and subsequent decades occurred 
as major consolidations were taking place in the U.S. and elsewhere with respect to 
health and safety issues, statistical foundations of dose-response relationships and 
governmental decisions of how to estimate risks from radiological and chemical 
hazards. At this point, the Arndt-Schulz Law became generally ignored and has con- 
tinued to be so. 
This brief assessment of the historical foundations of hormesis reveals that it was 
a theory without either a financial sponsor or a core of leading scientific propo- 
nents. In addition, U.S. science in the twentieth century became one that was nearly 
entirely dependent upon government agency f ~ ~ n d i n g  and responsive to its intellec- 
tual agenda, often supported by influential bodies such as the National Academy of 
Sciences. Lacking these crucial elements, hormesis was an l~ypothesis that failed to 
thrive. 
NEW OPPORTUNITIES AND INTEREST 
Major developments in environmental regulation over the past 40 years have 
provided the necessary incentive for the reexamination of the hormesis hypothesis. 
While this may not seem obvious, it is directly linked to the extraordinary conservative 
protectionist philosophy of governmental agencies such as the U.S. EPA in their 
risk-assessment procedures for carcinogens, which assume linearity at low doses. 
Such governmental actions have led to very high costs being imposed on affected 
industries and organizations such as the U.S. DOD and DOE. This led to interest 
not only in exploring the biological foundations of low-dose extrapolation but also 
alternative models of low-dose responses. It became very evident to those leading 
the aFfected organizations that if hormesis was right then linearity at low doses was 
wrong. At that point, the 1981 book by Luckey dealing with hormesis and ionizing 
radiation became potentially significant. Ironically, Luckey did not even mention any 
relationship between hormesis and carcinogenicity. Nonetheless, it sparked interest 
in the concept of radiation hormesis, especially in light of reports in the 1950s and 
1960s suggesting that low doses of radiation may reduce the risks of certain cancers 
in natural high background radiation settings (Luckey, 1991), as well as reports 
suggesting enhanced longevity in survivors of the atomic bomb blast (Kondo, 1993) 
and numerous animal model validation experiments during the 19'70s and 1980s 
(see Calabrese and Baldwin, 2002b for review). 
324 Nonlinearity in Biology, Toxicology, and Medicine. Vol. 1, No. 3, 2003 
6
Dose-Response: An International Journal, Vol. 1 [2007], Iss. 3, Art. 3
https://scholarworks.umass.edu/dose_response/vol1/iss3/3
Hormesis as Dose-Response Model 
This combination of factors and the leadership of the Electric Power Research 
Institute (EPRI) led to the first-ever conference on Radiation Hormesis in1985 in 
Oakland, California. Of particular note was that the proceedings were published 
two years later in the prestigious journal Health Plzysics, adding not only enhanced 
visibility to the topic but that elusive credibility that hormesis lacked. Several years 
later, Leonard Sagan (1989), who directed the 1985 EPRI conference, and Sheldon 
Wolff (1989) of the University of California at San Francisco debated the viability 
of hormesis as a credible biological hypothesis in the journal Science. Following the 
publication of the Sciencearticles a meeting was held in May 1990 at the University of 
Massachusetts, Amherst to devise a plan to provide balanced leadership for assessing 
how biological systems respond to low levels of chemical and physical stressors. Based 
on this meeting, the BELLE (Biological Effects of Low Level Exposures) organization 
was created that has played a significant role in assessing the hormesis concept (see 
commentary by Rodricks, 2003). 
OBJECTIVE EVALUATION 
By the mid-1990s the assessment of hormesis seemed to fall into groups that either 
thought it was a concept based on reproducible data or were unconvinced, generally 
concluding that the low-dose stimulation was most likely that of normal variation. 
These critics contended that the evidence in support of the hormesis hypothesis had 
simply been overinterpreted. 
In order to move beyond this impasse concerning hormesis, we developed apriori 
evaluative criteria to assess whether a dose-response displayed features consistent 
with the hormetic/biphasic dose-response. These criteriawere based on study design 
characteristics, such as whether the experiment displayed a NOAEL (No Observed 
Adverse Effect Level) and the number of doses less than the NOAEL, the magnitude 
of tlle low-dose stimulation, the presence or absence of statistical significance for the 
stimulatory effects, and the reproducibility of the findings. Each factor considered 
received a numerical ranking, which provided a basis for a mathematical algorithm 
to estimate the likelihood that each dose-response yielded evidence consistent with 
the hormetic Ilypothesis. We also developed a relational retrieval database into which 
information from numerous different content fields from each study could be en- 
tered. With tllese two tools, evidence from about 5000 experiments was accumulated 
that provided positive evidence of hormesis. An assessment of the findings indicates 
that hormetic dose-response relationships are very generalizable, being indepen- 
dent of biological model, endpoint measured and chemical class/physical stressor 
(Calabrese and Baldwin, 1997; Calabrese et al., 1999). Figure 3 provides a diverse 
set of examples of dose-response relationships that are consistent with the hormetic 
hypothesis. They were selected to demonstrate the range of biological models and 
endpoints in which hormetic responses may occur. 
The creation of this hormesis database using objective criteria was an impor- 
tant first step in the assessment of hormesis as a credible biological hypothesis. Of 
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Figure 3. Representative examples of U-shaped dose-response curves. The asterisks indicate 
statistically significant data. 
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importance was that the evaluative criteria were sufficiently specific and objective 
that they led to negligible variation among those evaluating dose responses for the 
presence or absence of evidence concerning hormesis. It was this type of consis- 
tency that was sought in order to overcome the disparity of the conclusions that 
proponents and opponents had expressed on the topic. 
An assessment of this database revealed important characteristics of hormetic 
dose-response relationships. Most notably, tlle magnitude of the low-dose stimulation 
was generally quite modest. In most cases tlle maximum stimulation did not exceed 
two-fold greater than the concurrent control group. The maximum response was 
generally about 30-60% greater than the control group response. The width of the 
stimulatory response was more variable than that of the magnitude of the low-dose 
stimulation. Typically the range of the stimulatory responses was within a factor of 
10-20 of the NOAEL dosage. In a small proportion of the cases tlle dosage range of 
the stimulation would exceed a factor of 100-fold. In addition, tllere were occasions 
when the stimulatory dosage range would reproducibly exceed 1000-fold. 
Of importance was that tlle hormetic stimulation was graphically contiguous with 
and ended at the traditional toxicological NOAEL (Figure 4). This allowed risk 
assessors the opport~~nity to place hormetic responses within a risk assessment dose- 
response context. This would prove to be the case not only for testing purposes 
within a hazard assessment framework but also for modeling of low-dose responses. 
The second reason is that the hormetic response was closely linked to the occur- 
rence of tlle initiation of toxicity. In fact, since 1896 (Townsend, 1896) the low-dose 
stimulation had been reported to occur as a result of an overcompensation to a 
disruption in homeostasis. In fact, this observation, which has been repeatedly re- 
ported (Calabrese, 2001), provides the foundation for why the hormetic response is 
invariably adjacent to the toxicological NOAEL. 
Maximum response 
I (averages 130-1 60% of control) 
d' Distance to NOAEL - 
Hormetic Zone 
(averages 10- to 20-fold) 
 
Increasing Dose --+ 
Figure 4. Dose-response curve depicting the quantitative features of hormesis. 
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That lzormesis may occur as a result of an overcompensation to low-level toxic 
insult accounts for why the stimulation is modest, based on the assumption that 
the disrupted biological process/system will re-establish homeostasis. Under such 
circumstances it would be expected that the biological processes would use suffi- 
cient resources to ensure that homeostasis is achieved within an appropriate time 
period but not to be wasteful of resources. This would result in a predicted modest 
"overshoot" phenomenon, which is what is typically observed with many hormetic 
dose-time responses. 
The quantitative characteristics'of the hormetic dose response are therefore con- 
sistent with expected features of a dose time response relationship in which there 
is an initial toxic response. The principal difference in responses between the low 
and high closes is that the lowdose toxicity becomes f~llly compensated and, in 
fact, modestly overcompensated, resulting in the apparent "stimulation." However, 
the high-dose toxicity remains unable to fully recover from the extensive damage 
and displays the so-called highdose "inhibition." Thus, when viewed at the appro- 
priate time in the dose-time response, the hometic-like biphasic dose response is 
observed. However, if the dose-time response is seen at an earlier stage of respon- 
siveness, then the dose response could appear as a traditional dosedependent toxic 
response (Figure 2). 
This initial assessment of horme tic responses not only yielded evidence to support 
the existence of hormesis but it also provided valuable toxicological insights. These 
findings permitted an evaluation of the generalizability of homesis as well as pro- 
viding a q~~antitative d scription of its dose-response features that were consistent 
with a plausible toxicological model of dose-time responsiveness. In fact, now it be- 
came clear why hormesis was hard to prove, challenging to replicate and a source of 
contention among those who had long debated its existence. The key for studying 
hormesis was to be found in the quality of the study design, such as the number 
and spacing of doses below the NOAEL, a definitively characterized NOAEL, and 
the inclusion of a temporal component that could capture the initial disruption in 
homeostasis followed by the modest overcompensation response. Likewise, it was 
critical to select an appropriate biological endpoint in which the control group had 
an adequate background response. For example, selection of a tumor type with an 
animal strain in which the control group had a negligible background incidence 
would preclude the assessment of hormesis. 
Despite the advances offered by the database-facilitated assessment of hormesis, 
it did not pennit an evaluation of the frequency of hormesis in the toxicological 
literat~lre. That is, while numerous, in fact thousands, of examples of dose-responses 
consistent with the hormetic hypothesis existed, this information offered no quan- 
titative insight concerning the frequency of hormetic responses in the toxicolog- 
ical literature. That is, did hormetic effects occur in 1% or 50% of toxicological 
studies, or someplace in between? This was an important issue to resolve for reg- 
ulatory agencies. If a response was real, but a relatively rare phenomenon, then it 
could be dealt with on a case-by-case basis. If, on the other hand, it was commonly 
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seen, then it would have to be considered as part of the "rule" and dealt with 
accordingly. 
To address the question of frequency, an entirely new database was created which 
had apriorientry as well as apn'olievaluative criteria (Calabrese and Baldwin, 2001a). 
These new criteria were applied to essentially every article (i.e., 21,000) published in 
three toxicologically oriented journals (i.e., Environmental Pollz~tion, Bulletin of Envi- 
ronmental Contamination and Toxicology and Life Sciences) from their creation (i.e., mid 
1960s) t o  the present. Thesejournals were selected because they included the spec- 
trum of ecologically to pharmacologically oriented toxicology. This was important 
in order to address issues related to generalizability by model, endpoint and agent. 
The data revealed that a priori entry criteria [i.e., a dose-response was required to 
have a LOAEL (Lowest Observed Adverse Effect Level), NOAEL, at least two doses 
less than the NOAEL dose and a concurrent control] were satisfied in only about 
2% of the articles assessed. However, of dose responses satisfylng the entry criteria 
approximately 40% satisfied apriori evaluative criteria, that is, the functional defini- 
tion of hormesis (e.g., evidence of statistically significwt responses for dosages less 
than the NOAEL dosage). 
The findings were important in several ways. For the first time there was an es- 
timate of the frequency of hormesis in the broad toxicological literature. This fre- 
quency revealed that hormetic responses were not rare occurrences and exceptions 
but were commonly reported. Second, the very low proportion of studies that satis- 
fied the apliorientry criteria indicated that the vast majority of toxicological studies 
has been incapable of assessing whether hormesis existed or not. These studies, for 
the most part, lack an adequate number of doses in the lowdose area and could not 
therefore discern whether there was a reliable low-dose stimulation or not. 
This insight was important because it provided a cogent explanation for how tox- 
icologists could readily dismiss hormesis. The data indicate that 98% of toxicology 
studies cannot address the hormesis hypothesis in an adequate evaluative fashion. 
Only about 50% of the 2% of dose-responses that could assess the hormetic hy- 
pothesis actually observed it. Consequently, only one out of every 100 published 
dose-response relationships assessed displayed hormesis. In effect, this type of nu- 
merical framework f ~ ~ r t h e r  emphasized the marginalized perspective within which 
the hormetic hypothesis has been held.3 
While this assessment addressed the issue of h o m e  tic effect frequency in the tox- 
icological literature, the second hormesis database (i.e., frequency database) also 
provided a vehicle to determine which toxicological dose-response model may be 
more frequent in the toxicological literature: the hormetic or the threshold model. 
The threshold model assumes that there is no treatment-related effect for doses 
Note that the criteria could have been even more stringent if temporal shtdy design 
criteria were also included. In fact, the lack of measurement at multiple time points in 
most experiments satisfylng the a@'ori criteria is a likely contributor to the reason why 
only 40% of the experiments satisfied the definition of hormesis. 
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below the NOAEL, a type of quasi-toxicological threshold dose. This f ~ ~ r t h e r  implied 
that responses of doses below the NOAEL dose would be expected to vary randomly 
on either side of the control value. For example, in our frequency database of about 
650 dose responses that satisfied a p~iori entry criteria, there were nearly 1,800 col- 
lective doses below the NOAEL. The threshold model predicts that there should 
be a similar number of responses above and below the control value. When this 
was evaluated, the ratio was not 1:l as predicted by the threshold model but 2.5:1, 
a value highly consistent with the hormetic model. Further, the mean response of 
the nearly 1,800 responses of doses below the NOAEL was 115%, a value consistent 
with past observations of hormetic responses (Calabrese and Baldwin, 2003a). These 
findings indicated that the responses of doses below the toxicological NOAEL were 
not randomly distributed butwere non-randomly distributed in a manner suggestive 
of hormesis. 
Not only did these findings reftlte the perspective of hormesis being a "paradox- 
ical" phenomenon, it also suggested that the long-held belief in the primacy of the 
threshold model may have been misplaced. This conclusion is of obvious general 
significance since acceptance of the hormetic model would infer profound changes 
in how studies are designed, biological models and endpoints selected, and risk 
assessments performed. 
The data also provided a framework to account for how the toxicological com- 
munity, especially mammalian toxicologists, could have missed the hormetic dose- 
response model and incorrectly concluded that the most fi~ndamental dose-response 
model ~ v a s  the threshold model. This conclusion is supported by several consistent 
observations. First, the NOAEL responses for about 70% of mammalian st~tdies in 
the frequency hormesis database were less than the control values. Even though 
these NOAEL responses were not, by definition, statistically significantly lower than 
the NOAEL, it is likely that a substantial proportion may have had a low level of 
toxicity, even if not discernable at the P < 0.05 level. Second, in dose responses that 
did not satisfy the functional definition of hormesis, where the NOAEL was 595% 
of the control, the next lower dose adjacent to the NOAEL had a response that was 
typically less than the control. At progressively lower doses from the NOAEL dose 
the responses resembled more hormetic responses (i.e., responses greater than the 
control) (Calabrese and Baldwin, 2003a). This finding suggests that the majority of 
mammalian toxicological st~tdies have NOAEL values less than the control, many 
probably have some degree of toxicity, and that toxicity may also be likely in the 
first dose below the NOAEL; this makes the phenomenon of hormesis difficult, if 
not impossible, to observe in such circumstances. Since most mammalian toxicology 
studies rarely have more than one dose below the NOAEL it follows that the logical, 
but incorrect, conclusion is that the most likely dose-response model would be the 
threshold model. As a result of this rather limited/incomplete st~tdy design-based 
perspective, the "collective" field of toxicology drew the wrong conclusion about the 
nature of the dose response in the low dose zone. In fact, it is our contention that 
simple limitation in the study design, which was focused on high-dose effects, led 
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to the apparently "logical" conclusion that hormesis was wrong and threshold was 
right, when in fact the fill1 range of data are consistent with the opposite conclusion. 
Despite these arguments in favor of the hormetic perspective, there has been 
one overriding criticism that toxicologists skeptical of hormesis consistently raise. 
That is, it is necessary to determine the mechanism(s) by which hormesis occurs. 
Unless the issue of mechanism can be resolved acceptance of hormesis would be 
seen as incomplete. A key limitation in the quest for the hormetic mechanism is 
that the overwhelming majority of papers p~lblished on toxicological mechanisms 
do not address the underlying explanations of transformations or switches in the 
dose-response relationships from stimulation to inhibition. However, this question is 
typically addressed in the sub-discipline of molecular pharmacology Our assessment 
of this literature has revealed that hoimetic-like biphasic dose-response relationships 
occ~lrred with seemingly comparable frequency in the pharmacology and toxicology 
domains. However, pharmacologists have both interest in switching mechanisms 
and the molecular tools to assess such changes. We have determined that hormetic- 
like biphasic dose response relationships have been reported in at least 30 receptor 
systems (Table 1) for which a highly credible molecular explanation has been offered 
at least to the level of receptor and often at levels of greater complexity (Calabrese 
and Baldwin, 2001b). 
These findings reveal that hormetic responses may occur as a result of nL1merous 
mechanisms, depending on the cell type. There was clearly no single toxicological 
mechanism. However, there appears to be a common biological regulatoiy strategy 
that results in the achievement of limited biological goals (e.g., smooth muscle con- 
traction/relaxation, regulation of neutrophil migration, cell proliferation enhance- 
ment or not) within the context of resource conservation while re-establishing and 
maintaining homeostasis. 
Table 1. Representative receptor systems displaying 
biphasic dose-response relationships 
Receptor systems displaying biphasic 
dose-response relationships 
Adenosine Neuropeptides 
Adrenergic Nitric oxide 
Bradykinin N-methyl-D-aspartate 
Cholecystotkinin Opioid 
Corticosterone Platelet-derived growth factor 
Dopamine Prolactin 
Endothelin Prostatglandin 
Epidermal growth factor Somatostatin 
Estrogen Spermine 
5-Hydroxytryptamine (serotonin) Testosterone 
Human chorionic gonadotrophin Transforming growth factor 
Muscarinic Tumor necrosis factor a 
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Over the past seven years, therefore, we have been able to demonstrate that: 
1) hormesis is widespread in the toxicological literature; 2) that it has consistent 
q~~antitative f atures of the dose response; 3) it is highly generalizable according 
to model, endpoint and chemical class; 4) it has a frequency in the toxicological 
literahwe that is approximately 40% using very rigorous objective criteria; 5) in 
head-to-head competition with the threshold model the hormetic model clearly 
outperforms it; 6) it has numerous underlying specific mechanisms. These findings 
challenge the most basic pillar of the toxicological community concerning what 
model best describes how biological systems responded to low levels of chemical 
and physical stressor agents. The data also challenge how toxicological studies are 
designed. That is, experiments with inadequate numbers of doses and dose spacing, 
which also lack a temporal component, are not going to be able to address the issue 
of hormesis. This is where the vast majority of toxicological studies reside. 
HOW CAN HORMESIS BE USED? 
The concept of hormesis changes how we think about toxicology and risk assess- 
ment. In the domain of hazard assessment,' hormesis argues that there are meaning- 
ful biological effects below the toxicological NOAEL. Over the past several decades 
toxicologists and reellatory agencies have been content to derive NOAELs based 
on the assumption that there were no treatment-related effects below the NOAEL. 
If this can no longer be assumed, then it challenges researchers and regulat.ory 
agencies to rethink their study designs and perhaps the biological models used and 
endpoints measured. 
The acceptance of hormesis as a default assumption in the risk assessment pro- 
cess is one that should be taken seriously. This is because of the overwhelming 
amount of data supporting it, especially those findings relating to its frequency in 
the toxicological literature, its dominance over the threshold model, its widespread 
generalizability and the fact that it is difficult to study unless adequate resources and 
time are allocated. To require that hormesis be proven for every case would place a 
substantial burden of both resources and time and for all practical considerations 
would limit the application of hormetic phenomenon when, in fact, the evidence 
argues that it is a general phenomenon. 
The area of carcinogen risk assessment is likely to yield the biggest impact of 
hormesis. The most obvious implication of the hormetic model is not that low doses 
of carcinogens may actually reduce cancer risk, but that thresholds for carcinogens 
exist. Even though hormesis was shown above to outperform the threshold model, 
it may be ironically used to support the conclusion that thresholds exist for carcino- 
gens. Unless hormesis can be demonstrated it is quite evident that thresholds for 
carcinogens will be nearly impossible to prove, as has been the case over the past 
two decades. 
While the focus of h is  paper is environmentally oriented, it is important not 
to ignore that the hormetic dose-response is quite common in pharmacology and 
other biological fields concernedwith dose-response relationships. Numerous drugs, 
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including antibiotics, anti-viral agents, an ti-tumor agents and other chemotherapeu- 
tic, as well as most peptides (see Calabrese and Balclwin, 2003a,b for their review), 
often display hormetic-like biphasic dose responses. Similar dose responses are seen 
for plant root exudates (Reigosa et al., 1999) and how they affect germination of 
f~lngal spores and the growth of plant systems in soil. Biphasic responses are quite 
common in the field of exercise science especially with respect to immune responses 
(Nieman, 2000). The hormetic dose response is therefore one that is most likely ba- 
sic to all biological disciplines, the implications of which have only recently begun 
to be specifically explored (Calabrese, 2000). 
REFERENCES 
Alexander, L.T. (1950). Radioactive materials as plant stimulants-field results. Agronomy J 
42:252-255. 
Bellevite, P., Andrioli, G., Lussignoli, S., Ortoloni, R., and Conforte, A. (1997). A scientific 
re-appraisal of the "principle of similarity." &fed Hypotlz 49:203-212. 
Bliss, C.I. (1935a). Estimating the dosage-mortality curve. JEcon Entomol25:646-647. 
Bliss, C.I. (1935b). The calculation of the dosage-mortality curve. Ann Appl Biol22:134167. 
Bliss, C.I. (1935~). The comparison of dosage-mortality data. Ann Appl Biol22:307-333. 
Calabrese, E.J. (2000). Societal implications of hormesis. JAppl Toxicol20 (2) :91-9 1. 
Calabrese, E.J. (2001). Overcompensation stimulation: a mechanism for hormetic effects. Cnt 
Rer, Toxicol 31 (4&5) :425470. 
Calabrese, E.J., and Baldwin, L.A. (2003a). The hormetic dose-response model is more com- 
mon than the threshold model in toxicology. Tox Sn'71:246-250. 
Calabrese, E.J., and Baldwin, LA. (2003b). Pep tides and Hormesis. Cnt Rm Toxicol (in press). 
Calabrese, E.J., and Baldwin, L.A. (2002a). Defining hormesis. Hzcman and Experimental Toxi- 
cology 21:91-97. 
Calabrese, E.J., and Baldwin, L.A. (2002b). Radiation Hormesis and Cancer. Hum Ecolog Risk 
Assmnt 8 (2) :327-353. 
Calabrese, E.J., and Baldwin, LA. (2001a). The frequency of U-shaped dose responses in the 
toxicological literature. Tox Sn' 62:330-338. 
Calabrese, E.J., and Baldwin, L.A. (2001b). Special Issue: Scientific Foundatioils of Hormesis 
(R.O. McClellan, Ed.). Crit Rm Toxicol, CRC Press, Boca Raton, FL, pp. 349-669. 
Calabrese, E.J., and Baldwin, L.A. (2001~).  U-shaped dose responses in biology, toxicology, 
and public health. Ann Rm Pub Hltlz 2235-33. 
Calabrese, E.J., and Baldwin, LA. (2000a). Chemical hormesis: its historical foundations as a 
biological hypothesis. Human Exper Toxicol 19:2-3 1. 
Calabrese, E.J., and Baldwin, LA. (2000b). The marginalization of hormesis. Hz~vnan Exper 
Toxicol19:3240. 
Calabrese, E.J., and Baldwin, L.A. (2000~).  Radiation hormesis: its historical foundations as a 
biological hypothesis. Human Exper Toxicol 19341-75. 
Calabrese, E.J., and Baldwin, L.A. (2000d). Radiation hormesis: the demise of a legitimate 
hypothesis. Human Exper Toxicol 19:76-84. 
Calabrese, E.J., and Baldwin, L.A. (2000e). Tales of two similar hypotheses: the risk and fall 
of chemical and radiation hormesis. Human Exper Toxicol 19:85-97. 
Nonlinearity in Biology, Toxicology, and Medicine. Vol. 1, No. 3, 2003 341 
23
Calabrese: The Maturing of Hormesis as a Credible Dose-Response Model
Published by ScholarWorks@UMass Amherst, 2007
E.J. Calabrese 
Calabrese, E.J., and Baldwin, L.A. (1997). The dose determines the stimulation (and poison): 
development of a chemical hormesis database. Int J Toxic01 16:545-559. 
Calabrese, E.J., Baldwin, L.A., and Holland, C.D. (1999). Hormesis: a highly generalizable 
and reproducible phenomenon with important implications for risk assessment. Risk Anal 
19261-251. 
Cicero, T.J., and Badger, T.M. (1977). Effects of alcohol on the hypothalamic pituitary gonadal 
axis in the male rat. JPhannacol Exp Tlier 201:427-433. 
Clark, A.J. (1937). Handbook ofExperinienta1 Plzannncology. Verlig Von Julius Springer, Berlin. 
Csaba, G., and Lantos, T. (1973). Effect of hormones on protozoa. Studies on the phagocytotic 
effects of histamine, 5-hydroxyhyptamine and illdoleacetic acid in Tetrahymena pyriformis. 
Cytobiol7:361-365. 
Duggar, B.M. (1936). Biological Effects of Radiation, Vol. 11. McGralv-Hill, Ne~vYork. 
Duggar, B.M. (1901). Physiological studies with reference to the germination of certain fun- 
gous spores. Bot Gaz 31:35-66. 
Eisemann, K, Totola, A., Jurcic, K, Pettit, G.R., and Wagner, H. (1995). Bryostatins 1,2 and 5 
activate human granulocytes and lymphocytes in vitro and invivo studies. Plzarnz Phannacol 
Lett 1:45-45. 
Elferink, J.F.R., and VanUffelen, B.E. (1996). The role of cyclic nucleotides in neutrophil 
migration. Gen Phamnac 27(2):357-393. 
Falk, I.S. (1923). The role of certain ions in bacterial physiology. A review (Studies of Salt 
Action, W) . Abstracts ofBacteriology 7:33-50; 57-105; 133-147. 
Finney, D.J. (1952). Probit Anahsis, A statistical treatment ofthe Sip~zoid Response Czirue. 2nd Ed. 
Cambridge Univ. Press, London. 
Gadd~un, J.H. (1953). Bioassays and mathematics. Plzarniacol Rev 5:57-134. 
Gelfand, E.W., Dosch, H.-M., Hastings, D., and Shore, A. (1979). Lithium: A modulator of 
cyclic AMP-dependent events in lymphocytes? Science 203(26):365-367. 
Hidalgo, E., and Dominpez, C. (2000). Growth-altering effects of sodium hypochlorite in 
cultured h~unan dermal fibroblasts. Life Sci 67:1331-1344. 
Hueppe, F. (1896). Principles ofBacteriology. Translated from the German by E.O. Jordon. The 
Open Court Publishing Company, Chicago. 
Jefferson, M.C., and Aguirre, M. (1980). Methanol tolerances and the effects of methanol on 
longevity and oviposition behavior in Drosophila pachea. Physiol Entomol5:265-269. 
Jensen, G.H. (1907). Toxic limits and stimulation effects of some salts and poisons on wheat. 
Bot Gaz 43:ll-44. 
Kahlenberg, L., and Tme, R.1-I. (1896a). On the toxic action of dissolved salts and their 
electrolytic dissociations. Preliminary paper. JAmer Med Assoc, July 15. 
Kahlenberg, L., and Tn~e ,  R.H. (189613). On the toxic action of dissolved salts and their 
electrolytic dissociation. Bot Gaz 22:81-124. 
Kitano, M., Ichihara, T., Matsuda, T., Wanibushi, H., Tamano, S. et al. (1998). Presence of a 
threshold for promoting effects of Phenobarbital on diethylnitrosamine-induced hepatic 
foci in the rat. Carcinogenesis 19:1475-1480. 
Kondo, S. (1993). Health Effects ofLozu-Leuel Radiation. Kinki University Press, Osaka, Japan. 
Levings, M.K. (1977). Effects of cadmium chloride on growth and pigments in Glycine max 
L., Qwcus  &a L., Acer saccharinum L., and Cucumis staivzls L. Masters Degree, Purdue 
University, Indiana, 7 3  pp. 
Nonlinearity in Biology, Toxicology, and Medicine. Vol. 1, No. 3, 2003 
24
Dose-Response: An International Journal, Vol. 1 [2007], Iss. 3, Art. 3
https://scholarworks.umass.edu/dose_response/vol1/iss3/3
Hormesis as Dose-Response Model 
Lippert, C., Seeger, H., Mueck, A.O., and Lippert, T.H. (2000).  The effects of A-ring and 
D-ring metabolites of estradiol on the proliferation of vascular endothelial cells. Life Sci 
673653-1658. 
Luckey, T.D. (1980) .  Hwmesk with ImnizingRadiation. CRC Press, Inc. Boca Raton, EL. 
Luckey, T.D. (1991) .  Radiation Honnesis. CRC Press, Inc., Boca Raton, FL. 
Marshall, M.S., and Hrenoff, A.K. (1937) .  Bacteriostasis. JInfectDis 61:42-54. 
kleduri, G.U., Kanangat, S., Bronze, M., Patterson, D.R., Meduri, C.U., Pak, C.,Tolley, E.A., and 
Schaberg, D.R. (2001) .  Effects of methylpreclnisolone on intracellular bacterial growth. 
Clin Ding Lab Immz~nol8:1156-1163. 
Nieman, D.C. (2000) .  Exercise effects on systemic immunity. In~mz~nol Cell Biol78:496-501. 
Nio, D.A., Moylan, R.N., and Roche, J.K. (1993) .  Modulation of T lymphocyte function by 
neuropeptides. Jhn~nuno l l50  (12)  5281-5258. 
Reigosa, M.J., Sanchez-kloreiras, A., and Gonzalez, L. (1999).  Ecophysiological approach in 
allelopathy. Cnt Rm Plant Sci 18(5):577-608. 
Rice, C.D., and Weeks, BA. (1989) .  Influence of tributyltin on i n  uitro activation of oyster 
toadfish macrophages. JAqz~atic Animal Hlth 1:62-65. 
Richet, C. (1905) .  De l'action de doses minuscules de substances sur la fermentation lactique. 
Arch Intern '1 rle Plysiol3:203-217. 
Richet, C. (1906-1907). De l'action de doses minuscules de substance sur le fermentation 
lacique-troisieme memoire-Periodes d'acceleration et ralentissement. Arch Intem'ldePlys- 
io14:18-50. 
Rodricks, J. (2003).  Hormesis and toxicological risk assessment. Toxicological Sciences 71:134- 
136. 
Sagan, L.A. (1989).  On radiation, paradigms, and hormesis. Science 245(4918):574. 
Schulz, H. (1887).  Zur lehre von der arzneiwirdung. Virchows Archivfiw Path01 Anatom und 
Physiol f i ~ r  Klinische Medbin 108:423-445. 
Southam, C.M., and Erhlich, J. (1943).  Effects of extracts of western red-cedar heartwood on 
certain wood-decaying fungi in culture. Plytopatl~ology 3 3 5  17-524. 
Subhadra, A.V., Nada, A.K., Behera, P.K., and Panda, B.B. (1991).  Acceleration of catalase 
and peroxidase activities in Lemna minor L. and Alliz~m cepa L. in response to low levels of 
aquatic mercury. Enuimn Pollut 69: 169-1 79. 
Tang, L., Mamotte, C.D.S., Van B o c h e e r ,  F.M., and Taylor, R.R. (1998).  The effect of 110- 
mocysteine on DNA synthesis in cultured h~unan vascular smooth muscle. Atherosclerosis 
136:169-173. 
Townsend, C.O. (1896).  The correlation of growth under the influence of injuries. Annals of 
Botany 11:509-532. 
Ullrich, T.L., and Storer, J.B. (1979).  Influence of gamma irradiation on the development of 
neoplastic disease in mice. 11. Solid tumors. Radiat Res 80:317-324. 
Waalkes, M.P. (1988) .  Cadmium carcinogenesis in male Wistar [Crl: (WI)BR] rats: dose- 
response analysis of tumor induction in the prostate and testes and at the injection site. 
CancerRes 48:465&4663. 
Winslo~v, C.-E.A., and Dolloff, A.E (1928).  Relative importance of additive and antagonistic 
effects of cations upon bacterial viability. JBacteriol15:67-92. 
Winslo~v, C.-E.A., and Haywood, E.T. (1931).  The specific potency of certain cations with 
reference to their effect on bacterial viability. JBacteriol22:49-69. 
WOE, S. (1989) .  Are radiation-induced effects hormetic. Science 245(4918):575. 
Nonlinearity in Biology, Toxicology, and Medicine. Vol. 1, No. 3,  2003 
25
Calabrese: The Maturing of Hormesis as a Credible Dose-Response Model
Published by ScholarWorks@UMass Amherst, 2007
